Oncology focused Rutherford Health said the expected completion date of its planned acquisition of Proton Partners International Health Care Investments had been pushed back.
Biotechnology company Allergy Therapeutics announced positive top line results from G309 exploratory field trial to evaluate efficacy and safety of its potential drug to treat...
Oil company President Energy said it was continuing to make steps towards spinning of its Atome Energy green hydrogen and ammonia company and listing it...
Intellectual property-based businesses developer IP Group said that following the completion of a funding round by a portfolio company in its top twenty most valuable...
Wholesale power generation businesses owner ContourGlobal reported a rise in funds from operation as revenue jumped in the nnine months through September, driven by a...